Wyman Robert T. - 02 Jun 2025 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: General Counsel
Issuer ticker: HHS
Reported as of: 02 Jun 2025
Net transaction value: +$113,750
SEC form: 4
Accepted by SEC: 03 Jul 2025, 13:07:47 UTC
Prior SEC filing: 27 May 2025
Source filing: View source filing
Reporting owner signature: Robert Wyman

Key filing fact

Wyman Robert T. filed Form 4 for HARTE HANKS INC (HHS) on 03 Jul 2025.

Key facts

This page summarizes Wyman Robert T.'s Form 4 filing for HARTE HANKS INC (HHS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jul 2025, 13:07.

Change

Previous filing in this sequence was filed on 27 May 2025.
Current net transaction value: +$113,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001416859 Primary reporting owner

Wyman Robert T.

Relationship: General Counsel
Address: 1 EXECUTIVE DRIVE, SUITE 303, CHELMSFORD
Signature: Robert Wyman
Signature date: 03 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HHS transaction

Common Stock

Award

Transaction value: $113,750
Shares: +25,000
Change %
Price: $4.55
Shares after: 25,000
Date: 02 Jun 2025
Ownership: Held by Harte Hanks until vested
Footnotes: F1

HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,217
Date: 02 Jun 2025
Ownership: Direct

HHS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,334
Date: 02 Jun 2025
Ownership: Held by Harte Hanks until vested
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Participant was granted 25,000 RSU shares on 6/02/2025 (contract signed on 7/03/25) which will vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.

Footnote F2

Participant was granted 12,500 RSU shares on 3/04/2024 which vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.

Footnote F3

Award No. 30101